1. Home
  2. PSN vs BLCO Comparison

PSN vs BLCO Comparison

Compare PSN & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Parsons Corporation

PSN

Parsons Corporation

HOLD

Current Price

$57.58

Market Cap

6.3B

Sector

Technology

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$16.00

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSN
BLCO
Founded
1944
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
EDP Services
Ophthalmic Goods
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
5.4B
IPO Year
2019
2022

Fundamental Metrics

Financial Performance
Metric
PSN
BLCO
Price
$57.58
$16.00
Analyst Decision
Strong Buy
Buy
Analyst Count
13
11
Target Price
$79.18
$18.45
AVG Volume (30 Days)
1.0M
340.4K
Earning Date
04-29-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
3.77
N/A
EPS
0.49
N/A
Revenue
$6,364,245,000.00
$5,101,000,000.00
Revenue This Year
$5.87
$8.65
Revenue Next Year
$7.61
$5.59
P/E Ratio
$117.51
N/A
Revenue Growth
N/A
6.47
52 Week Low
$46.88
$13.09
52 Week High
$89.50
$18.92

Technical Indicators

Market Signals
Indicator
PSN
BLCO
Relative Strength Index (RSI) 57.73 44.37
Support Level $48.16 $15.67
Resistance Level $58.88 $15.77
Average True Range (ATR) 1.93 0.43
MACD 0.26 -0.11
Stochastic Oscillator 78.10 1.16

Price Performance

Historical Comparison
PSN
BLCO

About PSN Parsons Corporation

Parsons Corp is a provider of technology-driven solutions in the defense, intelligence, and critical infrastructure markets. The business activities of the group are carried out through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment is a high-end service and technology provider to the U.S. government, delivering timely, cost-effective solutions for mission-critical projects, whereas the Critical Infrastructure segment provides integrated design and engineering services for complex physical and digital infrastructure around the globe. The company derives maximum revenue from Federal Solutions segment. Geographically, the company derives revenue from North America; Middle East; and Rest of the World, of which North America derives maximum revenue.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: